Blackrock Health Sciences Trust (BME) Receives News Impact Score of 0.39
News coverage about Blackrock Health Sciences Trust (NYSE:BME) has been trending positive this week, according to Accern. Accern rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of 0.39 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.3345190217191 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Blackrock Health Sciences Trust (NYSE BME) opened at $36.21 on Wednesday. Blackrock Health Sciences Trust has a 12-month low of $32.81 and a 12-month high of $38.00.
The firm also recently declared a monthly dividend, which will be paid on Thursday, March 29th. Shareholders of record on Thursday, March 15th will be given a $0.20 dividend. This represents a $2.40 annualized dividend and a yield of 6.63%. The ex-dividend date is Wednesday, March 14th.
BlackRock Health Sciences Trust is a non-diversified, closed-end management investment company (the Trust). The Trust’s investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.